See other companies on Welcome to the Jungle
Lumanity
Accelerating and optimizing access to medical advances
- 501-1000 employees
- B2B
- Analytics
- Market research
- Data Analysis
- MedTech
- Accessibility
- London, UK
Jump to section
Company mission
To provide illuminating insights, incisive thinking, and decisive action, ultimately, to build a healthier world.
Our take
Patients around the world have yet to experience the full benefits of the astounding medical breakthroughs in oncology, rare diseases, neurological sciences, and cell and gene therapies as there hasn’t been comparable innovation of market access and commercialisation models. Lumanity delivers actionable, transformative outcomes to accelerate and optimise access to medical advances by transforming data and information into real-world insights and evidence.
Formed from the merging of successful pharmaceutical and biotech organizations including Cello Health, Zipher Medical Affairs, and BresMed, plus its strategic acquisitions of Endpoint Outcomes and Innovative Edge, the company’s suite of market-leading software solutions supports the work and innovation of companies in over 50 countries.
The Arsenal Capital Partners-backed company has remained focused on furthering its own development and commercialisation strategies, launch capabilities, and creating best-in-class service offerings and is well set to remain a market leader in empowering medical advancement and accessibility solutions.
Steph
Company Specialist at Welcome to the Jungle
Benefits
- And More! (varies by location)
- Training & Development
- Hybrid Working Pattern
Company values
- Respect: Your opinion matters—your wellbeing matters
- Diversity: You can be you here. Our community is a diverse group of thinkers, dreamers, and problem-solvers—and we are stronger because of it
- Impact: The work you do here matters. Every day we make a difference towards building a healthier world
- Action: We closely follow our mantra: Incisive thinking, decisive action
Leadership
Jon Williams
(CEO, not founder)Former CEO of Arsenal Capital Partners' Value Demonstration Platform and Senior Advisor at Arsenal Capital Partners. Founder & former President and CEO at Evidera. Previous Senior Vice President at United BioSource Corporation and Senior Principal at The Boston Consulting Group.